Coherus BioSciences, Inc. Quarterly Operating Income (Loss) in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Coherus BioSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2013 to Q3 2024.
  • Coherus BioSciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.39M, a 80% increase year-over-year.
  • Coherus BioSciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$138M, a 25.5% increase year-over-year.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2023 was -$203M, a 20.9% increase from 2022.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2022 was -$257M, a 2.65% increase from 2021.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2021 was -$264M, a 269% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$138M -$6.39M +$25.6M +80% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$164M -$20.5M +$14M +40.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$178M -$42.5M +$25.2M +37.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$203M -$68.9M -$17.4M -33.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$186M -$32M +$48.4M +60.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$234M -$34.5M +$9.47M +21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$244M -$67.7M +$13.2M +16.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$257M -$51.5M -$11.9M -30.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$245M -$80.4M -$47.7M -145% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$197M -$44M -$19.8M -82.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$177M -$80.9M +$86.4M +51.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$264M -$39.5M -$56M -341% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$208M -$32.8M -$66.5M -197% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$141M -$24.2M -$89.5M -137% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$51.9M -$167M -$208M -510% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $156M $16.4M -$28.6M -63.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $185M $33.7M -$18.1M -35% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $203M $65.3M +$37.8M +138% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $165M $40.9M +$57.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $108M $45M +$106M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $2.23M $51.8M +$109M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$107M $27.5M +$72.4M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$179M -$16.6M +$25.4M +60.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$204M -$60.5M -$14M -30.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$190M -$57M -$357K -0.63% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$190M -$44.9M +$11.7M +20.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$202M -$42M +$30.4M +42% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$232M -$46.5M +$27M +36.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$259M -$56.6M -$141M -167% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$118M -$56.6M +$6.1M +9.72% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$124M -$72.4M -$8.07M -12.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$116M -$73.5M -$21.3M -40.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$94.7M $84.6M +$156M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$251M -$62.7M -$3.84M -6.52% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$247M -$64.4M -$27.6M -75.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$219M -$52.2M -$25.6M -96.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$193M -$71.2M -$64.8M -1009% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$129M -$58.9M -$41M -228% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$87.7M -$36.7M -$23M -167% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$64.7M -$26.6M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 -$6.42M +$360K +5.31% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$17.9M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$13.8M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 -$6.78M Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.